Rocket Pharmaceuticals

September 29, 2020

Key biotech catalysts approach

Important clinical data are expected in the fourth quarter from biotech companies including Madrigal, Arena, Rhythm and Forma.

December 20, 2019

Plenty of choice remains for buyers of gene therapy

Despite the recent flurry of gene therapy deals there is still a fairly extensive list of affordable companies out there.

December 12, 2019

Ash 2019 winners and losers

Data and M&A lifts buoyant biopharma companies from Fate Therapeutics to Rocket, though on share price gain Forty Seven wins Ash 2019.